Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it has an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine for prevention of COVID-19.
A third US company has released research data showing its coronavirus vaccine is safe and elicits an immune response. According to CNN, Novavax, Inc. released Phase 1 results on Tuesday. The data shows..